JPRN-UMIN000009549已完成未知
Azilsartan can restore circadian rhythm of the urinary sodium excretion - Azilsartan & Sodium Balance
Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences0 个研究点目标入组 40 人开始时间: 2012年12月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
Twenty patients has been enrolled to the study. Published on Physiological Report
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. previous treatment with ARB, or diuretics 2 months before enrollment 2. change in the antihypertensive medication 2 months before enrollment 3. contraindication to Azilsartan (history of allergic reaction to it, bilateral renal artery stenosis) 4. presence or possibility of pregnancy/lactation 5. HbA1c >9.0 % 6. GOT >100, or GPT >85 7. endocrine hypertension 8. accelerated o r malignant hypertension (progressive renal dysfunction with diastolic BP of >120-130 mmHg 9. serious conditions with congestive heart failure, coronary diseases, arrhythmia or systemic diseases 10. nephrotic syndrome (serum albumin <2.5 g/dl) 11. any reason for ineligibility suggested by the attending doctor
研究者
相似试验
已完成
不适用
Azilsartan Circadian and Sleep pressure the 1st studyGrade I or Grade II essential hypertension patientsJPRN-UMIN000009576ACS Society700
已完成
2 期
Efficacy and Safety of Azilsartan in Subjects With Essential HypertensionHypertensionNCT00759551Takeda555
已完成
2 期
Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionEssential HypertensionNCT01289132Takeda926
已完成
不适用
Azilsartan Circadian and Sleep PressureHypertensionNCT01762501Sogo Rinsho Médéfi Co., Ltd.957
撤回
4 期
A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.Essential Hypertension With Stable Angina and DyslipidemiaNCT02400775Takeda